Alzheimer's Disease and Tau and several other neurodegenerative diseases

http://www.nyas.org/UpcomingEventsByTopic.aspx?tid=a11038df-e3d5-47c4-ada8-0f1820ec2530

Upcoming Events by Topic

Friday, September 18, 2015 | 8:30 AM - 4:30 PM
Alzheimer's Disease and Tau: Pathogenic Mechanisms and Therapeutic Approaches

Speakers: George S. Bloom (University of Virginia), Peter Davies (Feinstein Institute for Medical Research), Marc I. Diamond (University of Texas, Southwestern Medical Center), Michael Hutton (Eli Lilly and Company), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Hartmuth C. Kolb (Johnson & Johnson, Janssen R&D), Nicole Leclerc (Université de Montréal), Richard Ransohoff (Biogen)
Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.



http://www.nyas.org/Events/Detail.aspx?cid=7baf1757-58a8-458f-b2da-6454bf65838c
Alzheimer's Disease and Tau: Pathogenic Mechanisms and Therapeutic Approaches

Friday, September 18, 2015 | 8:30 AM - 4:30 PM
The New York Academy of Sciences
Presented by the Brain Dysfunction Discussion Group
Poster Abstract Deadline:

• August 14, 2015

The Microtubule Associated Protein tau (MAPT or tau) is closely linked to Alzheimer's disease (AD), the Fronto-Temporal Dementias (FTDs) and several other neurodegenerative diseases. While it has long been recognized that tau aggregates to form neurofibrillary tangles (NFTs), a hallmark pathological lesion in AD and other disorders, emerging evidence demonstrates that tau has a mechanistically complex role in neurodegeneration. Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.
*Reception to follow.
Call for Poster Abstracts

Abstract submissions are invited for a poster session, and several abstracts will be selected for short ‘Late-breaking abstract’ presentations. For complete submission instructions, please send an email to [email protected] with the words "Abstract Information" in the subject line. The deadline for abstract submission is August 14, 2015.
This event will also be broadcast as a webinar.
Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City when possible.

qqqqqqq, I believe we are on the same vein of thinking?
"''Something is happening behind the scenes and uncertainty doesn't favour a higher sp so who then does it benefit? - cui bono....this stinks of big pharma but they'll only have a short window to play silly buggers before action is taken..''